The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes

May 25, 2018 updated by: Nurcan Buduneli, Ege University
Cigarette smoking is a patient-related factor that can affect healing of periodontal tissues and the success rate of root-coverage procedures. Neither the nature nor the mechanisms of action of cigarette smoking on root coverage are fully understood. Therefore, the hypothesis that cigarette smoking has negative impacts on the outcomes of root coverage after CAF surgery in systemically healthy individuals with an initial gingival thickness of at least 0.8 mm and who practice optimal oral hygiene was tested. It was also hypothesized that baseline analysis of disease-related biomarkers would shed light on the underlying mechanisms of a possible effect.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Maxillary central and lateral incisors, canines, and premolars and mandibular premolars with isolated buccal recessions classified as Miller Class I or II
  • Study tooth should present tooth vitality, identifiable cemento-enamel junction (CEJ) and absence of caries, restorations or extensive non-carious cervical lesion.

Exclusion Criteria:

  • Medical disorders such as diabetes mellitus, immunologic disorders, hepatitis
  • History of previous mucogingival surgery at the gingival recession site
  • Medications known to affect gingival tissues
  • Antibiotic treatment in the past 6 months
  • Pregnancy or lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Smoker Group
This group included smoker gingival recession patients.
The coronally advanced flap (CAF) is a procedure frequently used in periodontal plastic surgery. The main objective of this surgical technique is to mobilize the gingival margin and reposition it at a level more coronal (incisal direction) than its original location. CAF is mainly used for the treatment of gingival recessions.
Active Comparator: Non-smoker Group
This group included non-smoker gingival recession patients.
The coronally advanced flap (CAF) is a procedure frequently used in periodontal plastic surgery. The main objective of this surgical technique is to mobilize the gingival margin and reposition it at a level more coronal (incisal direction) than its original location. CAF is mainly used for the treatment of gingival recessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the percentage of root coverage
Time Frame: 1-month, 3-month and 6-month after coronally advanced flap (CAF)
Root coverage were measured on digital photographs using specific software.
1-month, 3-month and 6-month after coronally advanced flap (CAF)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the percentage of complete root coverage
Time Frame: 1-month, 3-month and 6-month after coronally advanced flap (CAF)
1-month, 3-month and 6-month after coronally advanced flap (CAF)
Change in gingival thickness
Time Frame: Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Gingival thickness was measured with an ultrasonic device that uses the pulse echo principle. Ultrasonic pulses are transmitted at intervals of 1 millisecond through the sound-permeable mucosa and reflected, in part, at the surface of the alveolar bone or tooth attributable to different acoustic impedance. When an acoustic signal is transmitted within 2 to 3 seconds, gingival thickness is digitally displayed with a sensitivity of 0.01 mm.
Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Changing of the gingival crevicular fluid (GCF) biomarkers
Time Frame: Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Changing of the salivary biomarkers
Time Frame: Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Baseline,1-month, 3-month and 6-month after coronally advanced flap (CAF)
Change in the visual analog scale (VAS) values
Time Frame: 1 to 7 day after coronally advanced flap (CAF)
The visual analog scale (VAS) was used to evaluate pain during the postoperative follow-up period. It consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The patient selects a whole number (0-10 integers) that best reflects the intensity of their pain, with 0 being the no pain and 10 being the worst pain.
1 to 7 day after coronally advanced flap (CAF)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2010

Primary Completion (Actual)

June 7, 2012

Study Completion (Actual)

January 7, 2013

Study Registration Dates

First Submitted

May 15, 2018

First Submitted That Met QC Criteria

May 25, 2018

First Posted (Actual)

May 30, 2018

Study Record Updates

Last Update Posted (Actual)

May 30, 2018

Last Update Submitted That Met QC Criteria

May 25, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on Coronally Advanced Flap

Subscribe